NCT00522470已完成4 期
Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels in Diabetic Women
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
We aimed to evaluate the effects of rosiglitazone on serum ghrelin and peptide yy levels in diabetic women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •newly diagnosed, drug naive women with type 2 diabetes
排除标准
- •presence of severe cardiovascular disease (eg, New York Heart Association class III or IV congestive heart failure or a history of myocardial infarction or stroke)
- •presence of thyroid, pituitary, nutritional, hepatic, renal, or neoplastic disorders
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic SyndromeMetabolic SyndromeNCT00314561Korea University Anam Hospital40
已完成
4 期
Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic PatientsDiabetes Mellitus, Type 2NCT00290394Baskent University25
已完成
不适用
Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected PatientsInsulin ResistanceNCT00483392University Medical Centre Ljubljana
终止
4 期
Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASHNASH (Non-alcoholic Steato-hepatitis)NCT01406704Seoul St. Mary's Hospital26
已完成
2 期
The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.Ischemia-Reperfusion InjuryThe Metabolic SyndromeNCT00405015Radboud University Medical Center13